Fourth Biennial Pulmonary Hypertension Symposium 2026

Fourth Biennial Pulmonary Hypertension Symposium 2026 is organized by AdventHealth Nicholson Center and will be held from Nov 12 - 13, 2026 at AdventHealth Nicholson Center, Celebration, Florida, United States of America.

Patient Day Course Overview:
This educational activity is designed for patients living with pulmonary hypertension (PH), their families, caregivers, and support partners to enhance their understanding of pulmonary hypertension and empower them to actively participate in their care. Through presentations led by multidisciplinary experts and patient advocates, participants will gain practical knowledge about pulmonary hypertension, available treatment options, medication administration, oxygen therapy, research opportunities, lung transplantation, and strategies for maintaining quality of life. The program also emphasizes shared decision-making, patient perspectives, and meaningful engagement with the healthcare team to help participants navigate their PH journey with greater confidence and knowledge.

Patient Day Course Objectives:
As a result of participation in this program, participants should be able to:

· Describe the basics of pulmonary hypertension, including how the condition develops and how it affects the body.

· Review currently available treatment options for pulmonary hypertension, including medication therapies and methods of administration.

· Identify practical strategies for managing pulmonary hypertension in daily life, including oxygen therapy, lifestyle considerations, and medication resources.

· Discuss the impact of pulmonary hypertension on intimacy, relationships, and quality of life.

· Recognize opportunities to participate in pulmonary hypertension clinical research and understand the importance of research in advancing patient care.

· Explain when lung transplantation may be considered as a treatment option for pulmonary hypertension.

· Describe the role of shared decision-making and effective communication in partnering with the healthcare team to support individualized care.

Physician/APP Day Course Overview:
This educational activity is designed for physicians, advanced practice providers, nurses, and other healthcare professionals involved in the care of patients with pulmonary hypertension to enhance their understanding of pulmonary hypertension, including its pathophysiology, at-risk populations, clinical presentation, diagnostic evaluation, and current treatment strategies. Special emphasis will be placed on multidisciplinary management, diverse patient populations, and emerging therapeutic and procedural approaches to care. Through a comprehensive review of evidence-based practices and evolving treatment options, participants will be better equipped to recognize pulmonary hypertension earlier, make informed clinical decisions, and optimize patient outcomes through timely diagnosis and appropriate management.

Physician/APP Day Course Objectives:
As a result of participation in this program participants should be able to:

· Review the timeline of treatment development for pulmonary hypertension (PH). 

· Describe the clinical presentation and management of pulmonary hypertension (PH) in patients with sarcoidosis.

· Explain the current approach to managing pulmonary hypertension (PH) in the presence of hereditary hemorrhagic telangiectasia (HHT).

· Discuss evidence-based management considerations for pregnant patients with pulmonary hypertension (PH).

· Apply shared decision-making principles in the management of patients with pulmonary hypertension (PH).

· Analyze the role of balloon pulmonary angioplasty in the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH).

· Assess the evaluation and management strategies for critically ill patients with pulmonary hypertension (PH).

· Evaluate the role of extracorporeal membrane oxygenation (ECMO) in the management of patients with pulmonary hypertension (PH).